Last reviewed · How we verify
Metformin and Rosuvastatin
Metformin and Rosuvastatin is a Small molecule drug developed by Jeil Pharmaceutical Co., Ltd.. It is currently in Phase 1 development. Also known as: Glucodown OR SR tablet and Crestor tablet.
At a glance
| Generic name | Metformin and Rosuvastatin |
|---|---|
| Also known as | Glucodown OR SR tablet and Crestor tablet |
| Sponsor | Jeil Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants (PHASE1)
- Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib (PHASE1)
- A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation. (PHASE1)
- Focusing on the Menopausal Transition to Improve Mid-Life Women's Health (PHASE2, PHASE3)
- A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together (PHASE1)
- Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016) (PHASE1)
- A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Metformin and Rosuvastatin CI brief — competitive landscape report
- Metformin and Rosuvastatin updates RSS · CI watch RSS
- Jeil Pharmaceutical Co., Ltd. portfolio CI
Frequently asked questions about Metformin and Rosuvastatin
What is Metformin and Rosuvastatin?
Metformin and Rosuvastatin is a Small molecule drug developed by Jeil Pharmaceutical Co., Ltd..
Who makes Metformin and Rosuvastatin?
Metformin and Rosuvastatin is developed by Jeil Pharmaceutical Co., Ltd. (see full Jeil Pharmaceutical Co., Ltd. pipeline at /company/jeil-pharmaceutical-co-ltd).
Is Metformin and Rosuvastatin also known as anything else?
Metformin and Rosuvastatin is also known as Glucodown OR SR tablet and Crestor tablet.
What development phase is Metformin and Rosuvastatin in?
Metformin and Rosuvastatin is in Phase 1.
Related
- Manufacturer: Jeil Pharmaceutical Co., Ltd. — full pipeline
- Also known as: Glucodown OR SR tablet and Crestor tablet
- Compare: Metformin and Rosuvastatin vs similar drugs
- Pricing: Metformin and Rosuvastatin cost, discount & access